Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (19)

« Back to Publications

Atom-level mechanism of tapasin-independent peptide editing by Major Histocompatibility Complex class I molecules

Turner S. et al, (2025)

Evidence of focusing the MHC class I immunopeptidome by tapasin.

Darley R. et al, (2025), Frontiers in immunology, 16

Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.

van Hateren A. and Elliott T., (2023), Current opinion in immunology, 83

De-risking clinical trial failure through mechanistic simulation.

Brown LV. et al, (2022), Immunotherapy advances, 2

The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editing.

van Hateren A. and Elliott T., (2021), Current opinion in immunology, 70, 138 - 143

Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.

Illing PT. et al, (2021), Frontiers in immunology, 12

Protein Plasticity and Peptide Editing in the MHC I Antigen Processing Pathway.

Elliott T. and van Hateren A., (2018), Biochemistry, 57, 1423 - 1425

Direct evidence for conformational dynamics in major histocompatibility complex class I molecules.

van Hateren A. et al, (2017), The Journal of biological chemistry, 292, 20255 - 20269

TAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway.

Neerincx A. et al, (2017), eLife, 6

Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control.

van Hateren A. et al, (2017), F1000Research, 6

Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.

Abdul-Jawad S. et al, (2016), Molecular therapy : the journal of the American Society of Gene Therapy, 24, 375 - 384

Surface expression, peptide repertoire, and thermostability of chicken class I molecules correlate with peptide transporter specificity.

Tregaskes CA. et al, (2016), Proceedings of the National Academy of Sciences of the United States of America, 113, 692 - 697

Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function.

van Hateren A. et al, (2015), Molecular immunology, 68, 98 - 101

TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.

Hermann C. et al, (2015), eLife, 4

Peptide-independent stabilization of MHC class I molecules breaches cellular quality control.

Hein Z. et al, (2014), Journal of cell science, 127, 2885 - 2897

Load More